A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Applications | FC |
Reactivities | Human |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Applications | FC |
Reactivities | Human |
SARS-CoV-2 N protein monoclonal antibody
Applications | ELISA, ICC, WB |
Reactivities | SARS-CoV-2 |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | ELISA, FC, IF |
Reactivities | Human |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | ELISA, FC, IF |
Reactivities | Human |
SARS-CoV-2 Spike protein RBD monoclonal antibody
Applications | ELISA |
Reactivities | SARS-CoV-2 |
Chikungunya virus human monoclonal antibody, clone E26D9
Applications | IF, Neutralize |
Reactivities | Human |
Chikungunya virus human monoclonal antibody, clone E26D9
Applications | IF, Neutralize |
Reactivities | Human |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Applications | FC |
Reactivities | Human |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
Chikungunya virus human monoclonal antibody, clone E26C4
Applications | IF, Neutralize |
Reactivities | Human |
CD38 monoclonal antibody (daratumumab biosimilar)
Applications | ELISA, FC |
Reactivities | Human |
CD70 monoclonal antibody (vorsetuzumab biosimilar)
Applications | ELISA, FC |
Reactivities | Human |